Mid-treatment cases are among the situations where sub-specialty review is most useful, because response assessment is where framework discipline matters most. We review imaging from any point in the treatment course, with attention to the timing of imaging relative to chemoradiation, targeted therapy, or stereotactic radiosurgery. Share the report with your treating team before any change to your treatment plan.
What if I’m mid-treatment — is my case suitable for review?
Reviewed by the Medical Editorial Board on
Medical Disclaimer
All medical content on this site is reviewed by our Medical Editorial Board.
This content is provided for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional. Read the full medical disclaimer here.
Related Content
- MRI Misdiagnosis: Common Errors and How to Avoid Them
- Radiology Report Second Opinion Faq´s: What Patients Ask
- How a Second Opinion Diagnosis Reveals Better Options
- MRI Second Opinion Made Simple: What You Need to Know
